Mounjaro in Ireland: What People Already on It Want to Know

Mounjaro contains the active substance tirzepatide and works as a dual GIP and GLP-1 receptor agonist — acting on appetite-regulating pathways to help many people feel fuller sooner and reduce overall appetite. It is supplied as a pre-filled pen and is typically injected once a week, with the dose started low and adjusted over time by the prescriber.

Because it is a prescription-only medicine, access in Ireland — as in most countries — requires an assessment by a qualified prescriber. How and where that happens, and what criteria apply, is something your own doctor or prescriber can advise on. GLP Trackr does not supply, source, or facilitate the obtaining of any medication.

What the injection involves

Mounjaro is injected under the skin (subcutaneous injection), typically into the abdomen, thigh, or upper arm. Rotating the injection site with each dose is generally recommended to support skin comfort over time. Your prescriber or the patient information leaflet that came with your pen is the right place to confirm the technique and site guidance that applies to you.

Commonly reported experiences

Many people taking Mounjaro report gastrointestinal effects — including nausea, indigestion, and changes in bowel habits — particularly in the early weeks or after a dose step-up. These are among the most commonly described experiences and often ease as the body adjusts, though this varies from person to person. If any side effect is severe, persistent, or worrying, contact your healthcare professional promptly. Side effects should be reported to your national pharmacovigilance scheme (such as the Health Products Regulatory Authority (HPRA) scheme in Ireland, or the UK Yellow Card scheme for those in Northern Ireland) as well as to your own prescriber.

For broader background on Mounjaro, see our Mounjaro overview hub. If you are based in or near Northern Ireland, you may also find our page on Mounjaro in Northern Ireland relevant.

Staying consistent on a weekly injection schedule — and understanding how your body is responding — is one of the most practical challenges of being on Mounjaro. GLP Trackr is a companion app built specifically for people already on Mounjaro or Wegovy, and the feature that tends to matter most from day one is dose and injection-site logging.

Each time you inject, you can record the dose strength, the date, and the site you used. The app then tracks your rotation history and suggests your next injection site automatically — meaning you never have to remember where you last injected. A gentle weekly reminder ensures your next dose does not quietly slip past.

Beyond the injection itself, GLP Trackr lets you log side effects and how you feel day to day, so that patterns — such as which days tend to be harder after a dose — become visible over time. That kind of personal data is genuinely useful to bring to your next prescriber appointment. The app includes a doctor report feature that summarises your journey in a clear, shareable format.

Weight, measurements, mood, energy, and food intake can all be tracked in the same place, giving you a complete picture of how your journey is progressing — not just what the scale says on any given morning.

Any questions about your dose, your schedule, or how the medicine is working for you should always go to your prescriber or doctor — they know your full history and are the right person to advise. GLP Trackr is a tracking tool, not a medical service.

You might also be curious about whether Mounjaro comes in tablet form — that page covers what is currently available.

Ready to bring some structure to your weekly routine? GLP Trackr is free to try for 7 days — download it on the App Store or Google Play and start logging your very next dose.